Visual content depicting climate activists emphasizes emotion and disruption, contrasting with the rational, data-driven ...
Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that ...
A groundbreaking study reveals promising efficacy and safety of 212Pb-DOTAMTATE for treating neuroendocrine tumors, paving the way for future trials.
YL VANCOUVER, BC, Oct. 27, 2025 /CNW/ – Walker Lane Resources Ltd. (TSXV: WLR) (Frankfurt: 6YL); “Walker Lane”) is pleased to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results